DK1653963T3 - Nasal farmaceutisk sammensætning piribedil - Google Patents

Nasal farmaceutisk sammensætning piribedil

Info

Publication number
DK1653963T3
DK1653963T3 DK04767691T DK04767691T DK1653963T3 DK 1653963 T3 DK1653963 T3 DK 1653963T3 DK 04767691 T DK04767691 T DK 04767691T DK 04767691 T DK04767691 T DK 04767691T DK 1653963 T3 DK1653963 T3 DK 1653963T3
Authority
DK
Denmark
Prior art keywords
piribedil
pharmaceutical composition
nasal pharmaceutical
nasal
composition
Prior art date
Application number
DK04767691T
Other languages
English (en)
Inventor
Herve Rolland
Patrick Wuthrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1653963T3 publication Critical patent/DK1653963T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04767691T 2003-07-17 2004-07-16 Nasal farmaceutisk sammensætning piribedil DK1653963T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308712A FR2857594B1 (fr) 2003-07-17 2003-07-17 Composition pharmaceutique pour l'administration par voie nasale de piribedil
PCT/FR2004/001867 WO2005009442A1 (fr) 2003-07-17 2004-07-16 Composition pharmaceutique pour l’administration par voie nasale de piribedil

Publications (1)

Publication Number Publication Date
DK1653963T3 true DK1653963T3 (da) 2007-04-10

Family

ID=33548200

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04767691T DK1653963T3 (da) 2003-07-17 2004-07-16 Nasal farmaceutisk sammensætning piribedil

Country Status (29)

Country Link
US (1) US20060204449A1 (da)
EP (1) EP1653963B1 (da)
JP (1) JP2007516947A (da)
KR (1) KR100807480B1 (da)
CN (1) CN100540004C (da)
AR (1) AR046808A1 (da)
AT (1) ATE349213T1 (da)
AU (1) AU2004258714A1 (da)
BR (1) BRPI0412681A (da)
CA (1) CA2532631C (da)
CY (1) CY1106013T1 (da)
DE (1) DE602004003955T2 (da)
DK (1) DK1653963T3 (da)
EA (1) EA011041B1 (da)
ES (1) ES2279435T3 (da)
FR (1) FR2857594B1 (da)
GE (1) GEP20074259B (da)
HR (1) HRP20070081T5 (da)
MA (1) MA27864A1 (da)
MX (1) MXPA06000641A (da)
MY (1) MY137747A (da)
NO (1) NO332776B1 (da)
NZ (1) NZ544460A (da)
PL (1) PL1653963T3 (da)
PT (1) PT1653963E (da)
SI (1) SI1653963T1 (da)
UA (1) UA85193C2 (da)
WO (1) WO2005009442A1 (da)
ZA (1) ZA200600240B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2540470C9 (ru) 2008-06-06 2015-07-20 Фарма Ту Б Лтд. Фармацевтические композиции для лечения болезни паркинсона
US20160022572A1 (en) * 2013-03-13 2016-01-28 N To B Ltd. Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
IT201800005117A1 (it) * 2018-05-07 2019-11-07 Acqua irradiata con energie elettromagnetiche per uso terapeutico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.
DE69434304T2 (de) * 1993-03-26 2005-12-29 Merkus, Franciscus Wilhelmus H.M. Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin
FR2710268B1 (fr) * 1993-09-22 1995-10-20 Adir Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs.
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
FR2742989B1 (fr) * 1995-12-29 1998-01-23 Adir Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
NZ501321A (en) * 1997-03-26 2001-04-27 Franciscus W Nasal Melatonin composition
EP0900567A3 (en) * 1997-09-05 2001-05-02 Pfizer Products Inc. Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
US20020002175A1 (en) * 2000-09-19 2002-01-03 Charanjit Behl Nasal delivery of apomorphine in combination with glycol derivatives
US20040028613A1 (en) * 2001-06-25 2004-02-12 Nastech Pharmaceutical Company Inc Dopamine agonist formulations for enhanced central nervous system delivery
FR2827516B1 (fr) * 2001-07-19 2003-09-19 Servier Lab Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone

Also Published As

Publication number Publication date
ZA200600240B (en) 2007-03-28
NO20060743L (no) 2006-02-16
CN1819828A (zh) 2006-08-16
HK1094153A1 (zh) 2007-03-23
HRP20070081T3 (hr) 2007-04-30
PT1653963E (pt) 2007-02-28
PL1653963T3 (pl) 2007-02-28
WO2005009442A1 (fr) 2005-02-03
UA85193C2 (ru) 2009-01-12
EP1653963B1 (fr) 2006-12-27
MXPA06000641A (es) 2006-03-30
JP2007516947A (ja) 2007-06-28
DE602004003955T2 (de) 2007-12-06
EP1653963A1 (fr) 2006-05-10
KR100807480B1 (ko) 2008-02-25
AU2004258714A1 (en) 2005-02-03
CN100540004C (zh) 2009-09-16
EA011041B1 (ru) 2008-12-30
NZ544460A (en) 2008-04-30
US20060204449A1 (en) 2006-09-14
SI1653963T1 (sl) 2007-04-30
CY1106013T1 (el) 2011-04-06
FR2857594A1 (fr) 2005-01-21
GEP20074259B (en) 2007-12-10
ES2279435T3 (es) 2007-08-16
CA2532631A1 (fr) 2005-02-03
NO332776B1 (no) 2013-01-14
CA2532631C (fr) 2011-01-04
KR20060031689A (ko) 2006-04-12
MY137747A (en) 2009-03-31
HRP20070081T5 (hr) 2007-08-31
ATE349213T1 (de) 2007-01-15
AR046808A1 (es) 2005-12-28
FR2857594B1 (fr) 2005-09-16
EA200600172A1 (ru) 2006-06-30
DE602004003955D1 (de) 2007-02-08
BRPI0412681A (pt) 2006-10-03
MA27864A1 (fr) 2006-04-03

Similar Documents

Publication Publication Date Title
ATE380544T1 (de) Umhüllte feste darreichungsform
DK1545662T3 (da) Lægemiddelindgivelsessystem
DK1587478T3 (da) Farmaceutisk sammensætning
PT1501534E (pt) Formulacoes farmaceuticas
DE502004003234D1 (de) Gegen missbrauch gesicherte darreichungsform
DE502004004205D1 (de) Gegen missbrauch gesicherte darreichungsform
BRPI0511900A (pt) composições farmacêuticas
DE602004017700D1 (de) Transmukosen verabreichung
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
CY2018005I2 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
IS8352A (is) Ný rópínírólsamsetning
DE60335075D1 (de) Flüssigkeitszerstäuber
NO20034556D0 (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
DE602004022810D1 (de) Mehrdosis-inhalator
NO20043489L (no) Sammensetning for inhalering
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
NO20034952D0 (no) Farmasöytiske forbindelser
DK1675637T3 (da) Inhalator
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
SI1653963T1 (sl) Farmacevtski sestavek piribedila za nazalno aplikacijo
NO20044164L (no) Farmasoytiske sammensetninger
PT1467737E (pt) Composicao farmaceutica orodispersivel de piribedil
DE112004001429D2 (de) Pharmazeutischer Wirkstoff
DE502004004196D1 (de) Ultraschall-stehwellen-zerstäuberanordnung